The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

15 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
511
MK2 INHIBITORS AND METHODS OF MAKING AND USING THE SAMEBDB
Gilead Sciences
6
ERGOLINE-DERIVED AGONISTS OF THE 5-HT2A RECEPTORBDB
Diamond Therapeutics Inc.
2
MethodsBDB
Intra-Cellular Therapies
392
IMIDAZOLO INDAZOLE COMPOUNDS AS JAK INHIBITORSBDB
Theravance Biopharma R&D Ip
16
Anti-cancer nuclear hormone receptor-targeting compoundsBDB
Nuvation Bio
713
2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitorsBDB
Ideaya Biosciences
83
2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinasesBDB
Array Biopharma
9
Composition for suppressing neuraminidase activity comprising geranylated flavonoid derived from Paulownia tomentosa as active ingredientBDB
Industry-Academic Cooperation Foundation Gyeongsang National University
25
Substituted imidazopyridazinesBDB
Bayer Intellectual Property
14
Antagonists of prostaglandin EP3 receptorBDB
Pfizer
541
Inhibitors of beta-secretaseBDB
Vitae Pharmaceuticals
1
Monoacylglycerol lipase inhibitors for the treatment of metabolic diseases and related disordersBDB
Janssen Pharmaceutica
189
Substituted imidazo[1,2-a]pyrimidines and —pyridinesBDB
Bayer Intellectual Property
4
(4-{4-[5-(benzooxazol-2-ylamino)-pyridin-2-yl]-phenyl}-cyclohexyl)-acetic acid useful for treating or preventing conditions or disorders associated with DGAT1 activityBDB
Novartis
120
Benzenesulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (RORγ(T))BDB
Galderma Research & Development